High Purity 540737-29-9 Tofacitinib citrate bakeng sa JAK Pathway Inhibitor Setšoantšo se Featured

Bohloeki bo Phahameng 540737-29-9 Tofacitinib citrate bakeng sa JAK Pathway Inhibitor

Tlhaloso e Khutšoanyane:

Bohloeki:≧99.0%

Boemo ba Boleng:Enterprise Standard kapa ho hlokahala

Bokhoni:35Kgs/Kgwedi

Shelf Life:Lilemo tse tharo

Kopo:Phekola ramatiki ea ramatiki, ramatiki ea psoriatic, ankylosing spondylitis le ulcerative colitis.

Molemo oa Sehlopha:Sehlopha se nang le boiphihlelo ba ho rekisa kantle ho naha se nang le koetliso ea litsebi fekthering

Re romelle lengolo-tsoibila Khoasolla joalo ka PDF

Lintlha tsa Sehlahisoa

LBH

Li-tag tsa Sehlahisoa

Sehlahisoalebitso	Tofacitinib Citrate
Litlhaloso tse tšoanang	(3R,4R) -1-(Cyanoacetyl) -4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-3-piperidinamine 2-hydroxy-1,2,3 - propanetricarboxylate;CP 690500-10;CP 690550-10;(3R,4R) -4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-1-piperidinepropanenitrile 2-Hydroxy-1,2,3-propanetricarboxylate
Nomoro ea CAS.	540737-29-9
Ponahalo	Ho tloha ho phofo e tšoeu ho isa ho e tšoeu
Foromo ea limolek'hule	C₁₆H₂₀N₆OC₆H₈O₇
Boima ba Molek'hule	504.50
Kopo	Kereiti ea meriana kapa sepheo sa lipatlisiso
Ho paka	Joalo ka kopo ea hau
Polokelo	Boloka ka lijaneng tse thata, tse sa keneleng khanya sebakeng se phodileng

Tofacitinib Citrate (CAS #540737-29-9)
LINTLHA	LIEKETSENG	LIPHETHO
Ponahalo	Ho tloha ho phofo e tšoeu ho isa ho e tšoeu	Tloha phofo e tšoeu
Boitsebiso	HPLC;IR;HNMR	E lumellana
Solubility	E qhibiliha ka har'a DMSO ka 100mg/ml, ha e qhibilihe hantle ka har'a ethanol, e qhibiliha hanyenyane metsing joalo-joalo.	E lumellana
Tahlehelo ka ho Omisa	≤0.5%	0.12%
Masalla ha a tuka	≤0.1%	0.05%
Litšepe tse boima	≤10ppm	E lumellana
Lintho Tse Amanang	Diastereomer (RS+SR) ≤0.1% Tšilafalo e le Mong ≤0.15% Kakaretso ea litšila ≤1.0%	0.05% 0.14% 0.18%
Enantiomorphism Isomers	≤0.2%	E lumellana
Metsoako e setseng	Ethanol ≤5000ppm Methanol ≤3000ppm Toluene ≤890ppm	E lumellana
Litaba tsa Citrate	36.2%~40%	37.8%
Bohloeki	≥99.0%	99.38%
Tlhahlobo	60.68% ~ 63.16% ea Tofacitinib INN 98% ~ 102% ea Tofacitinib Citrate INN	62.04% 99.12%
Qetello: E lumellana

Lintlha tsa Khampani

√ Boiphihlelo bo felletseng ba Management layer ho balateli ba lifeme le litsebi tse nang le boiphihlelo;
√ Boleng ke kamehla ho nahanela rona holimo, Strict QC tsamaiso;
√ lilemo tse 11 tse nang le boiphihlelo sehlopheng sa thekiso ea thepa kantle ho naha;
√ Lab e ikemetseng ya R&D;
√ Lithupelo tse peli tsa nako e telele tsa GMP;
√ Lisebelisoa tse ruileng tsa lifeme tse ngata tse sa sebetseng bakeng sa morero o hlophisitsoeng;
√ Sehlopha se sebetsang se sebetsang hantle se nang le tsela e tsitsitseng.
imgsaf